Funded Research

From the U.S. National Institutes of Health (NIH)

NIAID - Bioshield

Inhalation of dry powder aminoglycosides, targeted against two aerosolized Category A bioterrorism agents.

NIDA

Preclinical and clinical evaluation of oral nanoparticle drug to treat pain and opiate addition. Goal is to provide slower and more uniform release of the drug that is currently in use.

NIAID

Evaluate the pharmacokinetics and absorption of inhaled and oral nanoparticle formulations of chelating agent.

U.S. Navy

Using Nanotherapeutics thin film technology, developing a proprietary rapid vapor detection system for concealed explosives.